Published in: British journal of clinical pharmacology (2023)
Strong CYP3A4 induction and inhibition both resulted in a weak effect on the clinical exposures of SHR0302. These present studies provided valuable information that help inform SHR0302 dosing instructions and concomitant medication precautions.